BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20133078)

  • 1. Increased detection of lymphatic vessel invasion by D2-40 (podoplanin) in early breast cancer: possible influence on patient selection for accelerated partial breast irradiation.
    Debald M; Pölcher M; Flucke U; Walgenbach-Brünagel G; Walgenbach KJ; Höller T; Wolfgarten M; Rudlowski C; Büttner R; Schild H; Kuhn W; Braun M
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1128-33. PubMed ID: 20133078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases.
    Braun M; Flucke U; Debald M; Walgenbach-Bruenagel G; Walgenbach KJ; Höller T; Pölcher M; Wolfgarten M; Sauerwald A; Keyver-Paik M; Kühr M; Büttner R; Kuhn W
    Breast Cancer Res Treat; 2008 Dec; 112(3):503-11. PubMed ID: 18165897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of lymphovascular invasion in vulvar cancer by D2-40 (podoplanin) as a predictor for inguinal lymph node metastases.
    Braun M; Wardelmann E; Debald M; Walgenbach-Bruenagel G; Höller T; Wolfgarten M; Sauerwald A; Rudlowski C; Büttner R; Kuhn W; Pölcher M
    Onkologie; 2009 Dec; 32(12):732-8. PubMed ID: 20016234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of lymphovascular invasion diagnosed by lymphatic endothelium immunostaining in breast cancer patients.
    Tezuka K; Onoda N; Takashima T; Takagaki K; Ishikawa T; Wakasa T; Wakasa K; Hirakawa K
    Oncol Rep; 2007 May; 17(5):997-1003. PubMed ID: 17390035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009).
    Polgár C; Van Limbergen E; Pötter R; Kovács G; Polo A; Lyczek J; Hildebrandt G; Niehoff P; Guinot JL; Guedea F; Johansson B; Ott OJ; Major T; Strnad V;
    Radiother Oncol; 2010 Mar; 94(3):264-73. PubMed ID: 20181402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive lobular carcinoma of the breast: role of endothelial lymphatic marker D2-40.
    Laser J; Cangiarella J; Singh B; Melamed J; Chiriboga L; Yee H; Darvishian F
    Ann Clin Lab Sci; 2008; 38(2):99-104. PubMed ID: 18469353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences.
    Mohammed RA; Martin SG; Gill MS; Green AR; Paish EC; Ellis IO
    Am J Surg Pathol; 2007 Dec; 31(12):1825-33. PubMed ID: 18043036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.
    Pawlik TM; Perry A; Strom EA; Babiera GV; Buchholz TA; Singletary E; Perkins GH; Ross MI; Schecter NR; Meric-Bernstam F; Ames FC; Hunt KK; Kuerer HM
    Cancer; 2004 Feb; 100(3):490-8. PubMed ID: 14745864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate assessment of lymph vessel tumor emboli in invasive ductal carcinoma of the breast according to tumor areas, and their prognostic significance.
    Yamauchi C; Hasebe T; Iwasaki M; Imoto S; Wada N; Fukayama M; Ochiai A
    Hum Pathol; 2007 Feb; 38(2):247-59. PubMed ID: 17056095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of lymphatic invasion in early stage primary colorectal cancer with the monoclonal antibody D2-40.
    Walgenbach-Bruenagel G; Tolba RH; Varnai AD; Bollmann M; Hirner A; Walgenbach KJ
    Eur Surg Res; 2006; 38(5):438-44. PubMed ID: 16912482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of lymphatic invasion in primary melanoma with monoclonal antibody D2-40: a new selective immunohistochemical marker of lymphatic endothelium.
    Niakosari F; Kahn HJ; Marks A; From L
    Arch Dermatol; 2005 Apr; 141(4):440-4. PubMed ID: 15837861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between D2-40-labeled lymphatic vessel invasion and lymph node metastasis of breast cancer].
    Ding GP; Ye CS; Liu MF; Zhen LF; Liao JJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2301-3. PubMed ID: 20965831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential impact of preoperative magnetic resonance imaging of the breast on patient selection for accelerated partial breast irradiation.
    Kühr M; Wolfgarten M; Stölzle M; Leutner C; Höller T; Schrading S; Kuhl C; Schild H; Kuhn W; Braun M
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e541-6. PubMed ID: 21664064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of immunohistochemically detected blood and lymphatic vessel invasion in colorectal carcinoma: its impact on prognosis.
    Liang P; Nakada I; Hong JW; Tabuchi T; Motohashi G; Takemura A; Nakachi T; Kasuga T; Tabuchi T
    Ann Surg Oncol; 2007 Feb; 14(2):470-7. PubMed ID: 17103258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of lymphovascular invasion by D2-40 (podoplanin) immunoexpression in endometrial cancer.
    Weber SK; Sauerwald A; Pölcher M; Braun M; Debald M; Serce NB; Kuhn W; Brunagel-Walgenbach G; Rudlowski C
    Int J Gynecol Cancer; 2012 Oct; 22(8):1442-8. PubMed ID: 22964524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic vessel invasion detected by the D2-40 monoclonal antibody is an independent prognostic factor in node-negative esophageal squamous cell carcinoma.
    Imamura Y; Watanabe M; Nagai Y; Baba Y; Hirashima K; Karashima R; Iwatsuki M; Yoshida N; Kinoshita K; Kurashige J; Iyama K; Baba H
    J Surg Oncol; 2012 Mar; 105(3):277-83. PubMed ID: 22271500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2-40-positive lymphatic vessel invasion is not a poor prognostic factor in stage I lung adenocarcinoma.
    Shimizu K; Funai K; Sugimura H; Sekihara K; Kawase A; Shiiya N
    Pathol Int; 2013 Apr; 63(4):201-5. PubMed ID: 23692420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of pathological evaluation for lymphatic vessel invasion in invasive breast cancer.
    Ito M; Moriya T; Ishida T; Usami S; Kasajima A; Sasano H; Ohuchi N
    Breast Cancer; 2007; 14(4):381-7. PubMed ID: 17986803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of lymphatic invasion in primary gastric cancer by a new monoclonal antibody, D2-40.
    Yonemura Y; Endou Y; Tabachi K; Kawamura T; Yun HY; Kameya T; Hayashi I; Bandou E; Sasaki T; Miura M
    Hum Pathol; 2006 Sep; 37(9):1193-9. PubMed ID: 16938525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Objective assessment of lymphatic and blood vascular invasion in lymph node-negative breast carcinoma: findings from a large case series with long-term follow-up.
    Mohammed RA; Martin SG; Mahmmod AM; Macmillan RD; Green AR; Paish EC; Ellis IO
    J Pathol; 2011 Feb; 223(3):358-65. PubMed ID: 21171081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.